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Myocardial infarctionAbstract Primary percutaneous coronary intervention (pPCI) is considered the preferred reperfu-
sion strategy for patients presenting with ST-segment elevation myocardial infarction (STEMI).
This study compares the door-to-balloon (D2B) time between transradial vs. the transfemoral
approach in patients presenting with STEMI.
Methods: A retrospectively collected catheterization laboratory database was reviewed for the
consecutive patients presenting with a STEMI. Speciﬁc time parameters were recorded, and our
composite end points were time to revascularization, angiographic success, short term clinical
success, and procedural vascular complications.
Results: Radial PCI (r-PCI) was performed in 33 patients (67.3%) and in 16 patients (32.7%) PCI
was done through femoral artery (f-PCI). No signiﬁcant difference was observed in the pre-catheter
and catheter laboratory times. Mean times from emergency room door-to-catheter laboratory time
for r-PCI vs. f-PCI were 82.48 ± 37.42 and 76.29 ± 34.32 min, respectively (P= 0.636). The mean
time from patient arrival to the cardiac catheter laboratory-to-balloon inﬂation was 34.56 ± 14.2 in
the r-PCI group vs. 33.12 ± 12.56 min with the f-PCI group (P= 0.215). The total D2B time was
not signiﬁcantly different between r-PCI vs. f-PCI groups (100.32 ± 36.3 vs. 97.31 ± 30.37 min,
respectively, P= 0.522). Angiographic success rates were observed in 92.1% of the patients for
156 O. Tayeh, F. Ettorir-PCI, and in 87.5% for f-PCI (P= 0.712). There were no vascular complications in both groups.
Conclusions: Patients presenting with STEMI can undergo successful pPCI via radial artery with-
out compromising patient care.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Current practice guidelines consider primary percutaneous
coronary intervention (pPCI) the preferred reperfusion strat-
egy for patients presenting with ST-segment elevation myocar-
dial infarction (STEMI), conditional on the timely
performance of the PCI procedure.1 On the basis of current
American College of Cardiology/American Heart Association
guidelines,2 door-to-balloon time (D2B) has become a report-
able core measure of quality and correlates with outcomes in
high-risk and early presentation patients.3 Periprocedural
bleeding remains a major limitation of primary PCI because
of the need to administer potent antithrombotic agents.4 Previ-
ous data have established the strong association between ma-
jor bleeding after PCI and increased mortality.5–8 Substantial
efforts have been made to reduce the occurrence of periproce-
dural bleeding, from using vascular closure devices to the use
of antithrombotic agents associated with a lower bleeding
risk.9,10 Radial access during PCI has emerged as a promising
alternative to femoral access, as the primary PCI using the ra-
dial approach was associated with a fourfold reduction in ma-
jor bleeding.11 Radial artery access for diagnostic cardiac
catheterization received interest through the work of Cam-
peau12 twenty years ago, and subsequently for intervention
procedures by Kiemeneij et al.13 Since then, there has been
widespread adoption of transradial techniques outside of the
United States.14 Parts of Europe and Japan do 40% or more
of their cases using the radial artery, but in the United States
estimates are in the low single digits (2%), although those Uni-
ted States cardiologists and radiologists who have learned the
radial technique tend to use it for many, if not most, of their
patients.15 Reasons stated for slow acceptance in the United
States include a lack of training in the radial approach, greater
difﬁculty manipulating catheters, difﬁculty in achieving radial
access, uncertain radiation exposure, and a learning curve for
performing cardiac catheterization through the wrist.16 These
arguments against the use of the radial artery imply that great-
er time may be required to perform cardiac catheterization
using the radial artery. This importance of time may be great-
est for patients presenting with STEMI as survival directly
relates to reperfusion times (door-to-balloon).17–19 For
patients undergoing primary PCI for acute STEMI, potential
differences between radial PCI (r-PCI) and femoral PCI (f-
PCI) in D2B times have not been widely evaluated. This study
compares the transradial vs. the transfemoral approach time in
the intervention for patients presenting with STEMI.2. Methods
A retrospectively collected catheterization laboratory database
of consecutive patients presenting with a STEMI over a
23 months period (starting from March 2007 till the end of
January 2009) at a tertiary care hospital (Cardiothoracic
Department, Spedali Civili, Brescia University, Italy) wasreviewed for this analysis. We reviewed and studied patients
who presented to our hospital by ST-segment elevation myo-
cardial infarction according to the deﬁnition of Joint European
Society of Cardiology/American College of Cardiology Com-
mittee 2007.20–24 STEMI was identiﬁed by ECG either in the
hospital or in the ﬁeld, and cardiac catheterization laboratory
staff was directly notiﬁed by the emergency medicine physi-
cian. All patients received aspirin, clopidogrel, unfractionated
heparin, glycoprotein IIb/IIIa (abciximab), and other anti-
ischemic medications before or during the procedure according
to clinical decision of the attending physician and treating
interventionalist.
The study population was stratiﬁed according to arterial ac-
cess used to perform pPCI into 2 groups; radial group and
femoral group (r-PCI vs. f-PCI). The choice between femoral
or radial artery access was left to the discretion of the operator.
Attending operators and technical staff were experienced at the
transradial and transfemoral arterial access. The radial ap-
proach is the default strategy at the Brescia catheterization lab-
oratory – Spedali Civili. In accordance with institutional
policy, the femoral approach was favored for patients with
negative ﬁndings on the Allen test,12,25 and for patients with
coronary artery bypass grafts (CABG). Radial arterial access
was achieved in a standard fashion using commercial micro-
puncture kits. Intra arterial nitroglycerine (200 mcg) was used
as the primary antispasmodic. PCI was performed using 6 Fr
guiding catheters. At procedure completion, the sheath was re-
moved immediately and a compression by hemostatic band
was installed for 3 h. Femoral procedures were done using vas-
cular sheaths, which were placed using the Seldinger’s tech-
nique. PCI was performed using 6 Fr guiding catheters. After
the end of the procedure, the sheath was removed in the inten-
sive care unit 4–5 h after the procedure and manual compres-
sion was performed for a minimum of 15 min or until
satisfactory hemostasis had been achieved. This was followed
by placement of a compressive bandage for 6 h. Closure de-
vices were not used. Access was considered successful once
the sheath was inserted into the artery. Crossover between ini-
tial access approaches was also recorded and access was strat-
iﬁed based on the ﬁrst route of access attempted.
Speciﬁc time parameters were recorded: time from emer-
gency room arrival-to-patient arrival in catheter laboratory
(cath. lab.), time from patient arrival in catheter Laboratory-
to-balloon inﬂation and total D2B time (interval from the ﬁrst
emergency room arrival-to-the ﬁrst attempt at opening the ar-
tery by aspiration thrombectomy, balloon inﬂation, or direct
stenting in the infarct-related artery ‘‘IRA’’).
American college of cardiology/American heart association
task force on performance measures stated that ‘‘the goal of
pPCI is to restore ﬂow in the IRA’’.26 As we sought to deter-
mine whether the radial approach was associated with a suc-
cessful pPCI without increasing the time to revascularization,
our composite end points were the time from emergency room
door to revascularization, angiographic success, short term
clinical success27 (relief of signs and/or symptoms of
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cedure), and procedural vascular complications (deﬁned as ac-
cess site bleeding, digital ischemia, hematoma,
pseudoaneurysm, or AV ﬁstula formation). Angiographic suc-
cess in our study was deﬁned as a residual stenosis diameter
less than 20% in stented segments or <50% in balloon angi-
oplasty segments, in the presence of TIMI ﬂow grade III
(Thrombolysis In Myocardial Infarction28) in the target vessel
on a lesion-by-lesion basis. Short term clinical success was
judged by the absence of ischemic discomfort post pPCI, but
it may be unreliable for identifying failed or successful reperfu-
sion, so we used in addition ST-segment resolution on the 12-
lead ECG by more than 70% as an evidence of successful
reperfusion.27
2.1. Statistical analysis
The data was coded and computed on a statistical package for
social sciences SPSS version 17 for windows for statistical
analysis. Times measured were analyzed using a Student t test
and reported as mean values. Mean times are reported in
minutes along with one standard deviation from the mean.
Demographic information and complications were categorical
data, and were analyzed using a chi squared analysis. Signiﬁ-
cance was deﬁned as P< 0.05.
3. Results
Over the study period; 2143 PCI procedures were done in the
catheter laboratory, in which 2647 lesions were treated for a
total of 1824 patients. Primary PCI for patients with acute
STEMI constituted 462 procedures of the total PCI per-
formed, during which 507 coronary lesions were treated for
447 patients. Of these, 49 acute STEMI patients were included
in this registry, in which pPCI was done by the authors.
Radial PCI was performed in 33 patients (67.3%) and in 16
patients (32.7%) PCI was done through femoral artery. There
was no statistical signiﬁcant difference between the two groups
in age, gender, or coronary artery disease risk factors includ-
ing, diabetes, stroke, hypertension, smoking, dyslipidemia, or
prior MI, PCI, or CABG. Patients in the both groups, who
underwent inter-hospital transfer prior to the procedure were
statistically non signiﬁcant (radial: 57.5% vs. femoral:
50.0%, P= 0.617). The demographic data of the studied pop-
ulation are listed in Table 1.
In the f-PCI group, arterial access was achieved via the con-
tra lateral femoral artery following initial failure in 2 patients
and times recorded were included for the femoral artery access,
while there was no crossover from right radial artery access to
left radial or femoral artery in the radial group.
Single culprit vessel PCI was performed in all patients of
the f-PCI group and in 31 patients (93.93%) for the r-PCI
group, P= 0.63. Primary PCI was done for 2 vessels in two
patients of the radial group. Thirty eight lesions were treated
in 33 patients for the radial group, while in the femoral group
16 lesions were intervened upon. Residual stenosis was less
than 20% in stented segments or <50% in balloon angio-
plasty segments after pPCI occurred in 35 lesions (92.1%)
for the radial group vs. 14 lesions (87.5%) in the femoral
group, P= 0.712 (Table 2).In the femoral group, 14 lesions presented with TIMI ﬂow 0
(87.50%), 1 lesion with TIMI ﬂow 1 (6.25%) and other one le-
sion with TIMI ﬂow 2 (6.25%). Pre primary PCI vessel steno-
sis range was 90–100% of the index luminal diameter of the
vessel with a mean stenosis of 99.31 ± 2.50. Post primary
PCI, 14 lesions had TIMI ﬂow 3 (87.50%), 1 lesion with TIMI
ﬂow 0 (6.25%) and one lesion had TIMI ﬂow 2 (6.25%). Four-
teen lesions (87.5%) had a residual stenosis less than 20% in
stented segments or <50% in balloon angioplasty segments
(Table 2).
In the radial group, 20 lesions presented by TIMI ﬂow 0
(52.63%), 5 lesions with TIMI ﬂow 1(13.16%), 1 lesion with
TIMI 2 (2.63%) and 12 lesions had TIMI ﬂow 3 (31.58%).
Pre pPCI vessel stenosis range was 80–100% of the index lumi-
nal diameter of the vessel with a mean stenosis of
95.66 ± 6.76. Post pPCI, 37 lesions had TIMI ﬂow 3
(97.37%) and only one lesion had TIMI ﬂow 1(2.63%). Thirty
ﬁve lesions (92.1%) had a residual stenosis less than 20% in
stented segments or <50% in balloon angioplasty segments
(Table 2).
Angiographic success was achieved in 35 lesions (92.1%) in
radial pPCI vs. 14 lesions (87.5%) in the femoral pPCI,
P= 0.712. While short term clinical success rates were ob-
served in 30 patients (90.9%) for the radial group vs. 14 pa-
tients (87.5%) for the femoral group (P= 0.749) Table 3.
There were no procedural vascular complications in both
groups.
No signiﬁcant difference was observed in the pre-catheter
and catheter laboratory times. Mean times from emergency
room door-to-catheter laboratory time for r-PCI vs. f-PCI
were 82.48 ± 37.42 and 72.29 ± 34.32 min, respectively
(P= 0.636). The mean time from patient arrival to the cardiac
catheter laboratory-to-balloon inﬂation was 34.56 ± 14.2 in
the r-PCI group vs. 33.12 ± 12.56 min in the f-PCI group,
which is statistically non signiﬁcant (P= 0.215). The total
D2B time was not signiﬁcantly different between r-PCI vs.
f-PCI groups (100.32 ± 36.3 vs. 97.31 ± 30.37 min, respec-
tively, P= 0.522) Table 4.4. Discussion
Traditionally, primary PCI has been performed using the fem-
oral approach. The reluctance to use the radial approach has
stemmed from the perceived longer vascular access time and
the subsequent delay in reperfusion time, despite the ﬁndings
of fewer vascular complications, such as lower bleeding risk,
lower costs, greater patient comfort, shorter post procedural
hospitalization time, and lower mortality when transradial
artery access is used rather than transfemoral in many
studies.15,29–31
In the setting of pPCI, more than 2/3 of major bleeding
events are attributable to complications at the femoral access
site.32–34 Also, a femoral hematoma requiring transfusion is
an independent predictor of one year mortality.31 Potential
strategies to reduce the incidence of bleeding have included tai-
lored and monitored anticoagulant and antiplatelet therapies.
Rao et al.15 reported a signiﬁcantly lower risk of bleeding com-
plications in patients treated using the radial approach. In a
meta-analysis of randomized trials, radial access reduced
major bleeding by 73% compared with femoral access.35
Table 1 Patients demographics.
Radial PCI (N= 33 pts) Femoral PCI (N= 16 pts) P value
Age (year): range 36.00–86.00 31.00–87.00
Mean ± SD 62.82 ± 11.94 63.63 ± 16.19 0.85
Sex: male 26 pts (78.79%) 13 pts (81.25%) 0.841
Female 7 pts (21.21%) 3 pts (18.75%)
Height (cm): range 152.00–190.00 155.00–180.00
Mean ± SD 169.61 ± 8.79 169.69 ± 7.63 0.98
Weight (kg): range 45.00–130.00 50.00–121.00
Mean ± SD 82.00 ± 17.06 77.38 ± 13.99 0.35
BSA (m2): range 1.41–2.45 1.50–2.20
Mean ± SD 1.93 ± 0.23 1.86 ± 0.18 0.28
Diabetes mellitus, n (%) 25 (75.7%) 13 (81.25%) 0.75
Hypertension, n (%) 27 (81.8) 14 (87.5%) 0.66
Dyslipidemia, n (%) 23 (69.7%) 10 (62.5%) 0.73
Cerebrovascular disease, n (%) 3 (9.1%) 2 (12.5%) 0.81
Smoking, n (%) 20 (60.6%) 9 (56.2%) 0.62
Previous PCI, n (%) 8 (24.2%) 4 (25%) 0.83
Previous CABG, n (%) 0 (00%) 1 (6.2%) 0.77
Previous MI, n (%) 5 (15.1%) 2 (12.5%) 0.89
Inter-hospital transfer, n (%) 19 (57.5%) 8 (50.0%) 0.617
BSA, body surface area; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; pts,
patients.
158 O. Tayeh, F. EttoriWeaver et al.36 conducted a nonrandomized single center
study and he demonstrated that the PCI performed for STEMI
using radial artery access could be performed with shorter
door to balloon times compared with femoral artery access
in a center where a high volume of radial artery procedures
is performed (D2B was 76.4 ± 26.4 in r-PCI vs.
86.5 ± 27.6 min in f-PCI, P= 0.008). These results are reas-
suring in that they suggest the concerns and challenges of
adapting transradial techniques that do not appear to translate
into actual degradation of door-to-balloon times in the very
time sensitive care of STEMI patients.
These results differ from prior observational and random-
ized studies for acute myocardial infarction, where procedural
times were typically not signiﬁcantly different or were longer
when radial access was used.37–40 However, one meta analysis
noted signiﬁcant heterogeneity in procedural times based upon
the experience of the operators with shorter radial procedural
times for more experienced operators.41
Accessing the radial artery has often been deemed techni-
cally more challenging and time consuming.38 In the present
study, we did not observe any differences in either the time
from arrival to catheter Laboratory-to-balloon inﬂation time
or the time from emergency door-to-balloon inﬂation (D2B)
in both groups, which were 34.56 ± 14.2 in r-PCI vs.
33.12 ± 12.56 min in f-PCI and 100.32 ± 36.3 in r-PCI vs.
97.31 ± 30.37 min in f-PCI, respectively (P= 0.215 and
0.522).
Also Arzamendi et al.11 reported no signiﬁcant effect on
key procedural intervals between radial and femoral ap-
proaches (Time to puncture 9 ± 5 vs. 9 ± 6 min, Time to
revascularization 21 ± 9 vs. 23 ± 10 min and D2B 123 ± 63
vs. 129 ± 81 min, respectively ‘‘P=>0.05’’). He reported a
reduction in 1 year follow-up of major adverse cardiac events
(MACE), associated with using the radial approach among pa-
tients undergoing primary PCI, which was mainly attributable
to a reduction in mortality and target vessel revascularization
at 12 months, and this is consistent with the previous datalinking a reduction in mortality to lower bleeding complica-
tions among patients undergoing radial access.42–44 Also he
documented a strong association between lower bleeding rates
and reduced 12-month mortality among patients undergoing
radial-access PCI. The target vessel revascularization rates
were also lower in the radial group in his study, possibly be-
cause of the better post procedural TIMI ﬂow grade observed
in the radial group. Moreover, the greater use of optimal anti-
coagulant and antiplatelet therapies among patients undergo-
ing radial PCI might have achieved a more effective
antithrombotic milieu, with subsequent improvement in epi-
cardial ﬂow. In our study, we are in agreement with Arzamen-
di et al.11 regarding the key procedural intervals, as there was
no signiﬁcant difference between radial and femoral groups.
But regarding TIMI ﬂow; post procedure TIMI ﬂow 3 was
achieved in 97.37% and 87.50% for both radial and femoral
groups, respectively with no signiﬁcant difference in our study
(P= 0.139).
It has been argued that the transradial approach may be
associated with lower rates of angiographic and clinical suc-
cess. However the angiographic and short term clinical success
rates in our study for the pPCI in both radial and femoral
groups were not signiﬁcantly different. This latter point might
encourage centers with a low volume of radial procedures to
increase the number of procedures using this approach, espe-
cially in the setting of STEMI. Cruden et al.45 demonstrated
that, the transradial approach is safe and effective in patients
with STEMI undergoing rescue PCI following failed throm-
bolysis by appropriately trained operators.
In some studies, there has been a trend toward higher fail-
ure rates at crossing the lesion with a wire in radial access pro-
cedures.36–39 In our study, there was no signiﬁcant difference in
the failure to cross a lesion depending on arterial access used,
as we have only one patient in the femoral group, in whom we
failed to cross the lesion with a wire in a totally occluded vein
graft. So the higher failure rates at crossing the lesion, appears
to be an artifact in the literature of operator experience as it
Table 2 Procedural characteristics.
Radial pPCI Femoral pPCI P value
Vascular access crossover, n (%) 0 (00.00%) 2 (12.5%) 0.350
Vessels intervened upon, n (%):
One vessel 31 pts (93.93%) 16 pts (100%) 0.78
Two vessels 2 pts (6.07%) 0 (00.00%) 0.63
Three vessels 0 (00.00%) 0 (00.00%)
Lesions intervened upon, n (%):
Left main artery 1 (2.63%) 0 (0.00%) 0.512
Left anterior descending artery 13 (34.21%) 5 (31.25%) 0.833
Left circumﬂex artery 5 (13.16%) 2 (12.50%) 0.948
Right coronary artery 19 (50.00%) 8 (50.00%) 1.000
Bypass graft 0 (0.00%) 1 (6.25%) 0.120
Pre pPCI TIMI ﬂow grade, n (%):
TIMI ﬂow 0 20 (52.63%) 14 (87.50%) 0.015
TIMI ﬂow 1 5 (13.16%) 1 (6.25%) 0.461
TIMI ﬂow 2 1 (2.63%) 1 (6.25%) 0.520
TIMI ﬂow 3 12 (31.58%) 0 (0.00%) 0.011
Post pPCI TIMI ﬂow grade, n (%):
TIMI ﬂow 0 0 (0.00%) 1 (6.25%) 0.120
TIMI ﬂow 1 1 (2.63%) 0 (0.00%) 0.512
TIMI ﬂow 2 0 (0.00%) 1 (6.25%) 0.126
TIMI ﬂow 3 37 (97.37%) 14 (87.50%) 0.139
Residual stenosis, n (%)
Yes 35 (92.1%) 14 (87.5%) 0.712
No 3 (7.9%) 2 (12.5%)
Angiographic success of the pPCI 35 (92.1%) 14 (87.5%) 0.712
Pre pPCI stenosis % 80–100
(95.66 ± 6.76)
90–100
(99.31 ± 2.50
0.14
Post pPCI residual stenosis % 0.00–90.00
(9.97 ± 26.37)
00–100
(11.88 ± 27.80)
0.81
Length of lesion (mm) 8–35
(14.63 ± 5.52)
6–30
(15.13 ± 6.12)
0.77
Balloon diameter (mm) 1.50–3.5
(2.25 ± 0.46)
1.50–3
(2.20 ± 0.37)
0.71
Balloon length (mm) 10–20
(14.84 ± 2.88)
12–20
(15.40 ± 2.67)
0.52
Bare metal stent diameter (mm) 2.25–4
(3.15 ± 0.45)
2.50–3.5
(3.05 ± 0.38)
0.50
Bare metal stent length(mm) 12–28
(17.35 ± 4.48)
8–28
(16.29 ± 4.38)
0.45
Contrast volume (ml) 162–275
(213.9 ± 62)
158–260
(205.8 ± 41)
0.37
n, number; pts, patients; pPCI, primary percutaneous coronary intervention; TIMI, thrombolysis in myocardial infarction ﬂow, Residual
Stenosis, <20% in stented segments or <50% in balloon angioplasty segments; mm, millimeter.
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artery access experience performed the procedure.40
Radial artery access has been associated with a greater ac-
cess crossover rate, which reported to be 4–7% in previous
studies.38–47 The crossover rate in our study was (12.5%) in
the femoral group, while there was no crossover in the radial
group. The greater rate of success in radial approach in our
study could be attributed to the greater experience in the radial
access, as it is the default access in all the elective and emer-
gency procedures in catheter laboratory of Spedali Civili,
Brescia University, Italy. Weaver et al.35 stated that crossover
rates, which are typical component of many comparisons be-
tween radial and femoral techniques, are associated with theexperience level of the operator and expert in both techniques
may reduce time delays regardless of initial access site used
when problems arise.5. Conclusions
The results of this study support that, patients presenting with
STEMI can undergo successful PCI via the radial artery with-
out compromising patient care. Door to balloon time is not
increased by radial artery access compared with femoral artery
access, where the operator has a considerable experience using
the radial artery for coronary intervention.
Table 3 Clinical presentation of the studied population before and after PCI.
Radial pPCI Femoral pPCI P value
Systolic BP before pPCI (mmHg) 80–190
(132.33 ± 20.68)
80–160
130.00 ± 21.53)
0.96
Diastolic BP before pPCI (mmHg) 60–110
(77.88 ± 12.93)
50–110
(78.13 ± 15.48)
0.95
Systolic BP after pPCI (mmHg) 80–160
(124.55 ± 13.94)
90–150
(123.13 ± 16.62)
0.76
Diastolic BP after pPCI (mmHg) 60–100
(74.85 ± 9.06)
50–100
(72.81 ± 11.54)
0.50
Angina after pPCI, n (%):
No 30 pts (90.91%) 15 pts (93.75%) 0.733
Yes 3 pts (9.09%) 1 pt (6.25%)
Resolution of ST segment in ECG, n (%):
>70% 30 pts (90.9%) 14 pts (87.5%)
<70% 3 pts (9.1%) 2 pts (12.5%) 0.749
BP, blood pressure; pPCI, primary percutaneous coronary intervention; pts, patients.
Table 4 Procedural and process times measured from door to balloon inﬂation.
Radial pPCI Femoral pPCI P value
ER door-to-Cath. Lab. time (min) 14–231
(82.48 ± 37.42)
15–210
(76.29 ± 34.32)
0.636
Arrival to Cath. Lab.-to-balloon inﬂation time (min) 27–45
(34.56 ± 14.2)
25–43
(33.12 ± 12.56)
0.215
ER door-to-balloon inﬂation time (min) 49–269
(100.32 ± 36.3)
47–245
(97.31 ± 30.37)
0.522
ER, emergency room; Cath. Lab., catheter laboratory.
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There are some important limitations in this study. First, it is a
single-center study. Second, it should be emphasized that, this
study was a retrospective, non-randomized in patients under-
going primary PCI with acute STEMI. These, could only be
overcome by a prospective randomized controlled trial.
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